Fundraising Fox

Topaz Biosciences

Emeryville, US · Founded 2022 · Delaware corporation

Topaz develops enzyme-based skin care ingredients that selectively reduce harmful bacteria while preserving beneficial bacteria to rebalance the skin microbiome, targeting conditions such as eczema and acne. It uses a proprietary metagenomics platform and synthetic biology to discover and design enzymes derived from natural microbial diversity.

Founders & leadership

OL
Oliver LiuExecutive
CH
Caroline HadfieldExecutive
JS
Jennifer ShockExecutive

Board

TS
Teresa ShockBoard director

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 1 round · 2025

$1.4MraisedMar 2025 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Oliver LiuExecutive Officer, Director
  • Caroline HadfieldExecutive Officer
  • Jennifer ShockExecutive Officer, Director
  • Teresa ShockDirector
Offering amount
$3.2M
Amount sold
$1.4M
First sale
Mar 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Companies competing with Topaz Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Topaz Biosciences do?
Topaz develops enzyme-based skin care ingredients that selectively reduce harmful bacteria while preserving beneficial bacteria to rebalance the skin microbiome, targeting conditions such as eczema and acne. It uses a proprietary metagenomics platform and synthetic biology to discover and design enzymes derived from natural microbial diversity.
How much funding has Topaz Biosciences raised?
Topaz Biosciences has disclosed $1.4M raised across 1 round.
Where is Topaz Biosciences headquartered?
Topaz Biosciences is headquartered in Emeryville, US.